Log In
Print this Print this

PAK inhibitor

  Manage Alerts
Collapse Summary General Information
Company Afraxis Inc.
DescriptionP21 protein (Cdc42 Rac)-activated kinase 1 (PAK1) inhibitors
Molecular Target p21 protein (Cdc42 Rac)-activated kinase 1 (PAK1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCentral nervous system (CNS) disorders
Indication DetailsTreat central nervous system (CNS) disorders
Regulatory Designation
Partner Genentech Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today